MURASE, J. E. .; MUNERA-CAMPOS, M. .; HONG, H. C.- ho .; TAIEB, A. .; CHUNG, W.-H. .; RECK ATWATER, A.; RUEDA, M. J. .; ZHONG, J. .; BUZIQUI PIRUZELI, M. L. .; PAU-CHARLES, I. .; DELEURAN, M. . Lebrikizumab-Treated Patients With Atopic Dermatitis Had No Increase in Treatment-Emergent Adverse Events of Facial, Head, and Neck Erythema Compared to Placebo. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s272, 2023. DOI: 10.25251/skin.7.supp.272. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2383. Acesso em: 3 jul. 2024.